- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 45
Hualan Biological Vaccines hooks $292m
Hillhouse Capital and Chen Yi Investment are making a secondary investment in the Hualan Biological Engineering spinoff which is now valued at more than $1.9bn.
Mar 31, 2020GSK displays Lyell Immunopharma investment
The corporate owned a 15% stake in immunotherapy developer Lyell, which recently raised $493m, with a fair value of $203m as of the end of 2019.
Mar 30, 2020Corporate venturing deal net: 23-27 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 27, 2020Afterpay unveils AP Ventures fund
The corporate has a 44% stake in growth equity fund AP Ventures, which plans to invest more than $30m in a total of five or six portfolio companies.
Mar 25, 2020WestCap directs $40m to Addepar
The CreditEase-backed wealth management product developer has now raised in excess of $245m following an investment by growth equity investor WestCap.
Mar 24, 2020Corporate venturing deal net: 16-20 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 20, 2020RTL gets down to Bedrock
RTL has paid an undisclosed amount for a 50% stake in Bedrock, the vehicle through which M6 has spun off its catch-up television and streaming services.
Mar 17, 2020Corporate venturing deal net: 9-13 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 13, 2020Corporate venturing deal net: 2-6 March 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mar 6, 2020Transphorm shapes reverse merger
The semiconductor technology producer has gone public through a reverse merger with penny stock company Peninsula Acquisition and received $21.5m from investors including Marelli.
Mar 5, 2020
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.